GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 11/06/24
GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for AdultsBusiness Wire • 10/29/24
GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to ConsumersBusiness Wire • 10/16/24
GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference CallBusiness Wire • 10/10/24
GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)Business Wire • 09/26/24
GoodRx Reports Q2 Earnings With Increased Prescription Revenue But Subscription ChallengesBenzinga • 08/08/24
GoodRx Holdings, Inc. (GDRX) Misses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/08/24
Unveiling GoodRx (GDRX) Q2 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 08/06/24
Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira®PRNewsWire • 07/18/24
GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference CallBusiness Wire • 07/11/24